Loading...
•
Jun 30, 2023
Definitive Healthcare Q2 2023 Earnings Report
Reported financial results with revenue increasing by 12% year-over-year.
Key Takeaways
Definitive Healthcare reported Q2 2023 financial results with revenue of $61.0 million, a 12% increase year-over-year. The company's adjusted EBITDA was $17.2 million, representing 28% of revenue. The company is issuing financial guidance for Q3 2023 and full year 2023.
Revenue was $61.0 million, an increase of 12% from Q2 2022.
Net loss was ($11.6) million, or 19% of revenue.
Adjusted Net Income was $12.4 million, compared to $8.8 million in Q2 2022.
Adjusted EBITDA was $17.2 million, or 28% of revenue, compared to $16.3 million, or 30% of revenue in Q2 2022.
Forward Guidance
The Company is issuing financial guidance for Q3 2023 and full year 2023. This guidance includes the dilutive effect of the acquisition of Populi and assumes no change in external conditions.
Positive Outlook
- Revenue is expected to be in the range of $63.0 – $64.5 million, a 10-12% increase year over year.
- Adjusted Operating Income is expected to be in the range of $16.0 – $17.0 million.
- Adjusted EBITDA is expected to be in the range of $17.5 – $18.5 million.
- Adjusted Net Income is expected to be $9.5 – $10.5 million.
- Adjusted Net Income Per Diluted Share is expected to be $0.05 – $0.07 per share on approximately 156.9 million weighted-average shares outstanding.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...